Application of bioequivalence tests for combination products tops 87 items

The Korea Food and Drug administration says that the number of bioequivalence tests for combination drugs is 87, which accounts for about 29 percent of total 296 drugs, applied for January and September 2010.

Of the 87 items, the combination drugs of olmesartan medoxomil and hydrochlorothiazide led any others with 46, followed by glimepiride and metformine HCl with 34 and alendronate sodium ...